Good move forward I say. To summarise:Prof Peter Steinberg is...

Good move forward I say. To summarise:

Prof Peter Steinberg is going to begin the process to have the best compounds registered for eventual sales. To do this, he has to generate safety data (toxicity), which will be outsourced to an independent laboratories. Once this data is available, the registration process can begin.

This could be a better strategy than partnering as eventually more profits could go to biosignal. Maybe this is a point Orredsson and Steinberg disagree on?

Just hope they don't try to register it in russia. SLA is finding it a very long process...

Good to hear this though "The initiation of the registration process and the previously announced appointment of Dr Mike Ironside are important parts of Biosignal’s shift from a research to product development focus. Mike has very senior experience in industrial chemistry and bringing new chemicals to market, and will help drive the registration process"